Remove 2030 Remove Biosimilars Remove Pharmaceuticals
article thumbnail

Sandoz announces new global ‘Act4Biosimilars’ initiative, to improve patient access and increase adoption by at least 30% in 30+ countries by 2030

The Pharma Data

Sandoz, a global leader in generic and biosimilar medicines, today announced the launch of a new global initiative called ‘Act4Biosimilars’ to help address health inequity and inequality worldwide. Biosimilars match their respective reference medicine in terms of quality, safety and efficacy.

article thumbnail

Investment Trends in Pharmaceutical Research

DrugBank

Investment Trends in Pharmaceutical Research and Development Investing in the pharmaceutical sector presents a unique set of challenges and opportunities; let’s examine them in more detail.  Pharmaceutical Market Analysis The global pharmaceutical market revenue in 2024 is projected to be 1.15

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Sanofi delivered close to double-digit Q4 2020

The Pharma Data

Pharmaceuticals. Fourth-quarter 2020 Pharmaceutical sales increased 2.4% Fourth-quarter 2020 Pharmaceutical sales increased 2.4% In 2020, Pharmaceuticals sales increased 3.1% price, patients switching to Toujeo ® and biosimilar glargine competition. Pharmaceuticals business operating income. Specialty Care.

Vaccine 52
article thumbnail

Sanofi delivered close to double-digit Q4 2020 business EPS(1) growth at CER

The Pharma Data

Pharmaceuticals. Fourth-quarter 2020 Pharmaceutical sales increased 2.4% Fourth-quarter 2020 Pharmaceutical sales increased 2.4% In 2020, Pharmaceuticals sales increased 3.1% price, patients switching to Toujeo ® and biosimilar glargine competition. Pharmaceuticals business operating income. Specialty Care.

Vaccine 52
article thumbnail

Sanofi continued its growth trajectory. Strong increase in Q1 2021 business EPS(1) at CER

The Pharma Data

Pharmaceuticals. First-quarter 2021 Pharmaceutical sales increased 3.8% District Court for the District of Delaware asserting two method of use patents (US 10,583,110 and US 10, 716,777), both of which expire in October 2030. Pharmaceuticals business operating income. to €2,638 million. At CER, BOI increased 13.3%.

Vaccine 52